Department of Medicine, Studium Patavinum, University of Padova, Padua, Italy.
Department of Clinical and Experimental Medicine, University of Pisa, Italy.
Nutr Metab Cardiovasc Dis. 2023 Feb;33(2):323-330. doi: 10.1016/j.numecd.2022.11.024. Epub 2022 Dec 5.
BACKGROUND AND AIMS: Whether the association between very high HDL-cholesterol levels and cardiovascular mortality (CVM) is modulated by some facilitating factors is unclear. Aim of the study was to investigate whether the risk of CVM associated with very high HDL-cholesterol is increased in subjects with hyperuricemia. METHODS AND RESULTS: Multivariable Cox analyses were made in 18,072 participants from the multicentre URRAH study stratified by sex and HDL-cholesterol category. During a median follow-up of 11.4 years there were 1307 cases of CVM. In multivariable Cox models a J-shaped association was found in the whole population, with the highest risk being present in the high HDL-cholesterol group [>80 mg/dL, adjusted hazard ratio (HR), 1.28; 95%CI, 1.02-1.61; p = 0.031)]. However, a sex-specific analysis revealed that this association was present only in women (HR, 1.34; 95%CI, 1.02-1.77; p = 0.034) but not in men. The risk of CVM related to high HDL-cholesterol was much greater in the women with high uric acid (>0.30 mmol/L, HR 1.61; 95%CI, 1.08-2.39) than in those with low uric acid (HR, 1.17; 95%CI, 0.80-1.72, p for interaction = 0.016). In women older than 70 years with hyperuricemia the risk related to high HDL-cholesterol was 1.83 (95%CI, 1.19-2.80, p < 0.005). Inclusion of BMI in the models weakened the strength of the associations. CONCLUSION: Our data indicate that very high HDL-cholesterol levels in women are associated with CVM in a J-shaped fashion. The risk of CVM is increased by concomitant hyperuricemia suggesting that a proinflammatory/oxidative state can enhance the detrimental cardiovascular effects associated with high HDL-cholesterol.
背景和目的:极高的高密度脂蛋白胆固醇(HDL-C)水平与心血管死亡率(CVM)之间的关联是否受某些促进因素的调节尚不清楚。本研究旨在探讨高尿酸血症患者是否会增加与极高 HDL-C 相关的 CVM 风险。
方法和结果:在多中心 URRAH 研究中,根据性别和 HDL-C 类别对 18072 名参与者进行了多变量 Cox 分析。在中位数为 11.4 年的随访期间,发生了 1307 例 CVM。在多变量 Cox 模型中,整个人群呈 J 形关联,HDL-C 较高组的风险最高[>80mg/dL,调整后的风险比(HR),1.28;95%CI,1.02-1.61;p=0.031]。然而,一项性别特异性分析显示,这种关联仅存在于女性(HR,1.34;95%CI,1.02-1.77;p=0.034),而不存在于男性。在高尿酸血症(>0.30mmol/L,HR 1.61;95%CI,1.08-2.39)的女性中,与高 HDL-C 相关的 CVM 风险明显高于低尿酸血症(HR,1.17;95%CI,0.80-1.72,p 交互=0.016)。在年龄大于 70 岁且伴有高尿酸血症的女性中,与高 HDL-C 相关的风险为 1.83(95%CI,1.19-2.80,p<0.005)。将 BMI 纳入模型会削弱关联的强度。
结论:我们的数据表明,女性极高的 HDL-C 水平与 CVM 呈 J 形关联。同时伴有高尿酸血症会增加 CVM 的风险,这表明炎症/氧化状态可能会增强与高 HDL-C 相关的不良心血管效应。
Nutr Metab Cardiovasc Dis. 2023-2
Nutr Metab Cardiovasc Dis. 2023-2
Eur J Prev Cardiol. 2021-2-14
Signal Transduct Target Ther. 2024-8-28
Int J Mol Sci. 2023-4-10